Mafenide: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
'''Mafenide''' ([[International Nonproprietary Name|INN]]; usually as mafenide [[acetate]], trade name '''Sulfamylon''') is a [[sulfonamide (medicine)|sulfonamide]]-type medication. It was approved by the FDA in 1948. | |||
==Category== | ==Category== | ||
Revision as of 04:52, 9 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]
Overview
Mafenide (INN; usually as mafenide acetate, trade name Sulfamylon) is a sulfonamide-type medication. It was approved by the FDA in 1948.
Category
US Brand Names
FDA Package Insert
Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Overdosage | Clinical Studies | Dosage and Administration | How Supplied | Labels and Packages